Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Abstract Identifying concomitant Lewy body (LB) pathology through seed amplification assays (SAA) might enhance the diagnostic and prognostic work-up of Alzheimer’s disease (AD) in clinical practice and trials. This study examined whether LB pathology exacerbates AD-related disease progression in 79...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-52299-1 |